UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549


                               FORM 8-K

                            CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 19, 2004

           CareDecision Corporation. (OTCBB: CDED)
     (Exact name of Registrant as specified in charter)


           Nevada                000-33187           91-2105842
(State or other jurisdiction    (Commission       (I.R.S. Employer
     of incorporation)          File Number)       Identification)


 2660 Townsgate Road, Suite 300, Westlake Village, CA    91361
      (Address of principal executive offices)         (Zip Code)


Registrant's telephone number, including area code: (805) 446-1973


/1/


ITEM 9. REGULATION FD DISCLOSURE

     CareDecision Corporation ("CareDecision" or the
"Company") [OTCBB: CDED] disclosed April 13, 2004 new
developments to our previously announced strategic
partnership with DataFuzion Inc. ("Fuzion").

     The current agreement allows Fuzion access to our Wi-Fi
medical communications technologies.  According to terms of
the enhanced partnership, Fuzion is granted new licenses for
use of our MD@Desktop and patent-pending MD@Practice-Probe
medical technologies.  In return for the additional
technology sharing, valued by the two firms at $2.8 million,
CareDecision will receive a larger equity stake in Fuzion, a
majority of this stake is expected to be distributed to our
shareholders as a dividend.

     Fuzion has already developed medical software
applications to support our products and management believes
this enhanced partnership with Fuzion to be a benefit to our
shareholders.  Fuzion plans to immediately integrate our
MD@Desktop and MD@Practice-Probe software to their business
intelligence software.



Date: April 19, 2004.
      --------------


CareDecision Corporation


/s/ Keith Berman
----------------
Keith Berman, CFO


/2/